Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Treptora
- Development stage
- Unknown
- Lead developer
- Genvio Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Treptora is an oral, small-molecule thrombopoietin (TPO) receptor agonist developed and manufactured by Genvio Pharma Limited (also known as Genovi Pharmaceuticals). It is a generic formulation of eltrombopag. The drug acts by interacting with the transmembrane domain of the human TPO receptor, which stimulates the proliferation and differentiation of megakaryocytes from bone marrow progenitor cells, leading to increased platelet production. Treptora is indicated for the treatment of chronic immune thrombocytopenia (ITP) in adult and pediatric patients who have had an insufficient response to other therapies such as corticosteroids, immunoglobulins, or splenectomy. It is marketed as an affordable generic alternative to the brand-name product Promacta.
- Brand names
- Treptora
- Other names
- Treptora 50Treptora50Treptora-50EltrombopagEltrombopag 25mgEltrombopag25mgEltrombopag-25mgEltrombopag 50mgEltrombopag50mgEltrombopag-50mg
02
Targets
TPOR (Thrombopoietin receptor)
Beyond the preview
Go deeper on Treptora.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Treptora.